An antagonist for the leukemia inhibitory factor receptor inhibits leukemia inhibitory factor, cardiotrophin-1, ciliary neurotrophic factor, and oncostatin M.
about
Astroglial expression of the P-glycoprotein is controlled by intracellular CNTF.The N-terminal cytokine binding domain of LIFR is required for CNTF binding and signalingCharacterization of a powerful high affinity antagonist that inhibits biological activities of human interleukin-13Esrrb is a direct Nanog target gene that can substitute for Nanog function in pluripotent cellsReceptor recognition sites of cytokines are organized as exchangeable modules. Transfer of the leukemia inhibitory factor receptor-binding site from ciliary neurotrophic factor to interleukin-6.Affinity maturation of leukemia inhibitory factor and conversion to potent antagonists of signaling.Leukemia inhibitory factor secretion is a predictor and indicator of early progenitor status in adult bone marrow stromal cells.IL-6 type cytokine receptor complexes: hexamer, tetramer or both?Receptor recognition by gp130 cytokines.Characterization of the rat oncostatin M receptor complex which resembles the human, but differs from the murine cytokine receptorFunctional characterization of W147A: a high-affinity interleukin-11 antagonistA unique loop structure in oncostatin M determines binding affinity toward oncostatin M receptor and leukemia inhibitory factor receptorPreconditioning-induced protection from oxidative injury is mediated by leukemia inhibitory factor receptor (LIFR) and its ligands in the retinaBox 2 region of the oncostatin M receptor determines specificity for recruitment of Janus kinases and STAT5 activation.Leukemia inhibitory factor and its receptor promote adipocyte differentiation via the mitogen-activated protein kinase cascade.Differential response of neuronal cells to a fusion protein of ciliary neurotrophic factor/soluble CNTF-receptor and leukemia inhibitory factor.Mutations in the immunoglobulin-like domain of gp190, the leukemia inhibitory factor (LIF) receptor, increase or decrease its affinity for LIF.
P2860
Q24798696-8C320555-4D4D-4471-A30B-52CDD096543AQ28119167-8BE593CF-DC05-4661-BAF2-7AD23508275AQ28208081-95B1BFD8-7242-4D6D-8CE6-DF9BACA9E165Q28910216-369000B0-569F-4A78-8ABD-741BE65CE460Q30322247-C19BB879-8A07-424C-836D-18F1D238BD54Q30823978-4ED8CACE-BFE1-40CB-8ED4-F1F60E3C2402Q33603565-B874BE38-806C-4330-BA5E-5FCD90C929AEQ33737244-C9E5377A-C8A3-434F-8161-32BDE8BACD9BQ33931723-9A04C5CB-ED78-45A7-BA18-CB0A51F16F54Q34398986-DE807AD9-9AF4-4A28-862C-536415451080Q35113678-1F3594F9-5BDE-4C9A-B99D-2907F10FCA35Q36294699-760259AF-BC75-4665-A23B-4E0A2C6C8EBDQ37195035-E395E0C3-FE77-44D6-9137-BB59DF14756AQ39989369-D908B621-C86A-4014-952D-EA1BE55F80BDQ42811748-BA688C5E-1D83-4A1E-A8F1-CFE22DC9799CQ44033127-231D127F-E625-48F9-8AC3-6643D0635B54Q50335902-3EF0E21D-1F80-42B5-B956-261A7AFBFADB
P2860
An antagonist for the leukemia inhibitory factor receptor inhibits leukemia inhibitory factor, cardiotrophin-1, ciliary neurotrophic factor, and oncostatin M.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
An antagonist for the leukemia ...... phic factor, and oncostatin M.
@en
type
label
An antagonist for the leukemia ...... phic factor, and oncostatin M.
@en
prefLabel
An antagonist for the leukemia ...... phic factor, and oncostatin M.
@en
P2093
P2860
P356
P1476
An antagonist for the leukemia ...... phic factor, and oncostatin M.
@en
P2093
A B Vernallis
K R Hudson
P2860
P304
26947-26952
P356
10.1074/JBC.272.43.26947
P407
P577
1997-10-01T00:00:00Z